{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:39:27Z","timestamp":1793741967327,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key Basic Research Program of China","award":["2015CB5540007"],"award-info":[{"award-number":["2015CB5540007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572866"],"award-info":[{"award-number":["81572866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773104"],"award-info":[{"award-number":["81773104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773263"],"award-info":[{"award-number":["81773263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873931"],"award-info":[{"award-number":["81873931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974382"],"award-info":[{"award-number":["81974382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education","award":["113044A"],"award-info":[{"award-number":["113044A"]}]},{"name":"Natural Science Foundation Program of Hubei Province","award":["2015CFA049"],"award-info":[{"award-number":["2015CFA049"]}]},{"name":"Natural Science Foundation Program of Hubei Province","award":["2017CFB652"],"award-info":[{"award-number":["2017CFB652"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2017KFYXJJ241"],"award-info":[{"award-number":["2017KFYXJJ241"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Scientific and Technological Innovation Projects in Hubei Province","award":["2018ACA136"],"award-info":[{"award-number":["2018ACA136"]}]},{"DOI":"10.13039\/501100003172","name":"HUST","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003172","name":"HUST","doi-asserted-by":"crossref","award":["WJ2019M155"],"award-info":[{"award-number":["WJ2019M155"]}],"id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.biomaterials.2020.120388","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:30:08Z","timestamp":1600363808000},"page":"120388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment"],"prefix":"10.1016","volume":"269","author":[{"given":"Qilin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunruo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biomaterials.2020.120388_bib1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Canc. Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.120388_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmed.2008.02.002","article-title":"Immunogenicity of anthracyclines: moving towards more personalized medicine","volume":"14","author":"Apetoh","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"6263","key":"10.1016\/j.biomaterials.2020.120388_bib3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2020.120388_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120388_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120388_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Canc."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120388_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120388_bib9","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1021\/acsnano.8b05189","article-title":"Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the Ido-1 pathway","volume":"12","author":"Lu","year":"2018","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120388_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2020.120388_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2014.05.019","article-title":"Improving the distribution of Doxil(R) in the tumor matrix by depletion of tumor hyaluronan","volume":"191","author":"Kohli","year":"2014","journal-title":"J. Contr. Release"},{"issue":"27","key":"10.1016\/j.biomaterials.2020.120388_bib12","article-title":"Nanomaterial-based organelles protect normal cells against chemotherapy-induced cytotoxicity","volume":"30","author":"Zhao","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib13","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120388_bib14","doi-asserted-by":"crossref","first-page":"1700339","DOI":"10.1002\/advs.201700339","article-title":"Radiation-sensitive dendrimer-based drug delivery system","volume":"5","author":"Wu","year":"2018","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120388_bib15","doi-asserted-by":"crossref","first-page":"1602567","DOI":"10.1002\/smll.201602567","article-title":"Safe and effective reversal of cancer multidrug resistance using sericin-coated mesoporous silica nanoparticles for lysosome-targeting delivery in mice","volume":"13","author":"Liu","year":"2017","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120388_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"Ido in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120388_bib17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2020.120388_bib18","doi-asserted-by":"crossref","first-page":"15207","DOI":"10.1038\/ncomms15207","article-title":"Blockade of Ido-kynurenine-AhR metabolic circuitry abrogates IFN-gamma-induced immunologic dormancy of tumor-repopulating cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120388_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Canc. Cell"},{"key":"10.1016\/j.biomaterials.2020.120388_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, Ido, and T-regs in the melanoma tumor microenvironment is driven by CD8(+) T cells,","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120388_bib21","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2005-10-4077","article-title":"Toward the identification of a tolerogenic signature in Ido-competent dendritic cells","volume":"107","author":"Orabona","year":"2006","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.biomaterials.2020.120388_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood-2008-12-195073","article-title":"Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells","volume":"114","author":"Jurgens","year":"2009","journal-title":"Blood"},{"issue":"48","key":"10.1016\/j.biomaterials.2020.120388_bib23","doi-asserted-by":"crossref","first-page":"20768","DOI":"10.1073\/pnas.1009201107","article-title":"An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120388_bib24","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120388_bib25","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120388_bib26","first-page":"551","article-title":"Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor","volume":"9","author":"Rundhaug","year":"2003","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.120388_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.imbio.2013.06.012","article-title":"Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001","volume":"218","author":"Kis-Toth","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.biomaterials.2020.120388_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41427-018-0027-4","article-title":"Amphiphilic dendrimer engineered nanocarrier systems for co-delivery of siRNA and paclitaxel to matrix metalloproteinase-rich tumors for synergistic therapy","volume":"10","author":"Li","year":"2018","journal-title":"NPG Asia Mater."},{"issue":"32","key":"10.1016\/j.biomaterials.2020.120388_bib30","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1016\/j.biomaterials.2011.07.038","article-title":"Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery","volume":"32","author":"Ping","year":"2011","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120388_bib31","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1021\/acs.nanolett.6b01432","article-title":"Highly integrated nano-platform for breaking the barrier between chemotherapy and immunotherapy","volume":"16","author":"Zheng","year":"2016","journal-title":"Nano Lett."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2020.120388_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-1759(02)00013-3","article-title":"A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells","volume":"262","author":"Son","year":"2002","journal-title":"J. Immunol. Methods"},{"issue":"31","key":"10.1016\/j.biomaterials.2020.120388_bib33","doi-asserted-by":"crossref","first-page":"26473","DOI":"10.1021\/acsami.8b05232","article-title":"Supramolecular modular approach toward conveniently constructing and multifunctioning a pH\/redox dual-responsive drug delivery nanoplatform for improved cancer chemotherapy","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120388_bib34","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/acsnano.6b04989","article-title":"Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors","volume":"10","author":"Ye","year":"2016","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.biomaterials.2020.120388_bib35","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/adfm.201302988","article-title":"Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer- targeted drug delivery in vivo","volume":"24","author":"Zhang","year":"2014","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijbiomac.2010.04.003","article-title":"Polyethyleneimine-protein interactions and implications on protein stability","volume":"47","author":"Mazzaferro","year":"2010","journal-title":"Int. J. Biol. Macromol."},{"issue":"14","key":"10.1016\/j.biomaterials.2020.120388_bib37","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/adma.201405084","article-title":"Interfacing materials science and biology for drug carrier design","volume":"27","author":"Such","year":"2015","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.120388_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","article-title":"Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses","volume":"67","author":"Hou","year":"2007","journal-title":"Canc. Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120388_bib39","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.biomaterials.2020.120388_bib40","first-page":"5456","article-title":"Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model","volume":"60","author":"Tillman","year":"2000","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120388_bib41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis e Sousa","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1084\/jem.20092203","article-title":"CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation","volume":"208","author":"Tze","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120388_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2008-11-191197","article-title":"Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells","volume":"114","author":"Chung","year":"2009","journal-title":"Blood"},{"issue":"46","key":"10.1016\/j.biomaterials.2020.120388_bib44","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.120388_bib45","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.120388_bib46","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4049\/jimmunol.1100016","article-title":"CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment","volume":"187","author":"Nair","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2014.07.005","article-title":"Radiotherapy and immunogenic cell death","volume":"25","author":"Golden","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.120388_bib48","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/0008-5472.CAN-16-0549","article-title":"Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming","volume":"76","author":"Rodriguez-Ruiz","year":"2016","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.120388_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Canc."},{"issue":"38","key":"10.1016\/j.biomaterials.2020.120388_bib50","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1021\/jacs.6b06663","article-title":"Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy","volume":"138","author":"Lu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120388_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2018.00101","article-title":"Regulation of CD8(+) T cells and antitumor immunity by notch signaling","volume":"9","author":"Tsukumo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120388_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","article-title":"How tolerogenic dendritic cells induce regulatory T cells","volume":"108","author":"Maldonado","year":"2010","journal-title":"Adv. Immunol."},{"issue":"6970","key":"10.1016\/j.biomaterials.2020.120388_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","article-title":"T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases","volume":"427","author":"Mempel","year":"2004","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biomaterials.2020.120388_bib54","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ijc.27755","article-title":"Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment","volume":"132","author":"Fransen","year":"2013","journal-title":"Int. J. Canc."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.120388_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jso.25091","article-title":"Prognostic value of intra-tumoral CD8(+)\/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis","volume":"118","author":"Sideras","year":"2018","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.120388_bib56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells","volume":"116","author":"Quezada","year":"2006","journal-title":"J. Clin. Invest."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220306347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220306347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:05:22Z","timestamp":1758906322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220306347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"alternative-id":["S0142961220306347"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120388","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"120388"}}